Potential candidate genes for azole antifungal agents and the development of torsade de pointes are genes encoding drug-metabolising enzymes such as CYP2C19 and CYP2C9 which are involved in the metabolic clearance of azoles3 and genes encoding cardiac ion channels such as KCNH24. This evidence concerns the gene CYP2C19 and torsades de pointes.